Business Context and Reporting Period
This Form 8-K Current Report was filed by Bristol-Myers Squibb Company on January 22, 2018. The report discloses a change in senior management effective February 15, 2018, and March 30, 2018.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial performance data.
Material Changes
The material change reported is the appointment of a new Senior Vice President and Controller and the retirement of the incumbent.
- Appointment: Ms. Karen Murphy Santiago will be appointed Senior Vice President and Controller, effective February 15, 2018.
- Retirement: Mr. Joseph Caldarella, current Senior Vice President and Controller, will retire on March 30, 2018.
Management Commentary and Risks
Ms. Santiago joined the company in 2003 and has held various finance roles, most recently as Vice President, Lead for Enabling Functions and Finance Transformation. She holds an M.B.A. in Finance, a B.S. in Accounting, and is a Certified Public Accountant. The filing states there are no family relationships between Ms. Santiago and any director or executive officer, and she is not a party to any arrangement regarding her selection or any transaction requiring disclosure under Item 404(a) of Regulation S-K.
Investor Verification Checklist
- Confirm the effective date of Ms. Santiago's appointment (February 15, 2018).
- Verify the retirement date of Mr. Caldarella (March 30, 2018).
- Review Ms. Santiago's internal tenure and prior roles within the company.
- Confirm the absence of undisclosed compensatory arrangements or family relationships as stated in the filing.